Temasek Participates in Series B Round in Homology Medicines
Posted on 08/03/2017
Sovereign wealth capital keeps on targeting gene editing companies. Gene editing could have major implications on global health. China has been very aggressive in the field of gene editing in recent years. Bedford, Massachusetts-based Homology Medicines Inc., a genetic medicines company translating proprietary gene editing and gene therapy technologies for many uses, raised US$ 83.5 […]
- Alternatives
- Asia
- gene editing
- healthcare
- Homology Medicines
- North America
- Temasek Holdings
- US
- Venture Capital
